why choose us

First received: March 09, 2023

Clinical Trial: Cryoablation+Ipilimumab+Nivolumab in Melanoma

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Metastatic Melanoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Advanced Melanoma Receiving Post-progression Dual Immune Checkpoint Inhibitor Therapy

Brief Summary: The aim of this study is to find out whether the combination of two approved drugs, ipilimumab and nivolumab, in combination with cryoablation are safe and effective for participants who have an unresectable melanoma that is resistant, or is growing, after receiving immunotherapy with a PD-1 inhibitor.The names of the study interventions involved in this study are:Cryoablation (an interventional radiology procedure that freezes part of a tumor)Ipilimumab (an immunotherapy)Nivolumab (an immunotherapy)

Read more